{
  "trial_info": {
    "title": "Validation of AI-Powered Cardiovascular Risk Prediction in Space and Earth Analogs",
    "phase": "Phase II Clinical Validation",
    "type": "Prospective, Multi-center, Comparative Effectiveness Study",
    "primary_endpoint": "Accuracy of CV risk prediction vs. standard clinical assessment",
    "secondary_endpoints": [
      "Time to cardiovascular event detection",
      "Clinical decision support effectiveness",
      "User acceptance and usability",
      "Cost-effectiveness analysis"
    ],
    "duration": "24 months",
    "estimated_enrollment": 200
  },
  "study_populations": {
    "astronauts": {
      "target_n": 50,
      "inclusion_criteria": [
        "Active astronaut status",
        "Age 25-65 years",
        "Cleared for spaceflight",
        "Baseline cardiovascular assessment completed"
      ],
      "exclusion_criteria": [
        "Pre-existing cardiovascular disease",
        "Pregnancy",
        "Contraindications to biomarker collection"
      ],
      "primary_sites": [
        "NASA Johnson Space Center",
        "ESA European Astronaut Centre"
      ]
    },
    "bedrest_analogs": {
      "target_n": 100,
      "inclusion_criteria": [
        "Healthy volunteers age 25-65",
        "Participating in 30+ day bedrest study",
        "Normal baseline cardiovascular function"
      ],
      "exclusion_criteria": [
        "History of cardiovascular disease",
        "Diabetes mellitus",
        "Current medication affecting cardiovascular system"
      ],
      "primary_sites": [
        "DLR Institute of Aerospace Medicine",
        "NASA Flight Analogs Research Unit"
      ]
    },
    "clinical_controls": {
      "target_n": 50,
      "inclusion_criteria": [
        "Hospital patients with CV risk factors",
        "Age-matched to space populations",
        "Standard CV risk assessment indicated"
      ],
      "exclusion_criteria": [
        "Acute cardiovascular events",
        "Unable to provide informed consent"
      ],
      "primary_sites": [
        "Mayo Clinic",
        "Cleveland Clinic",
        "Johns Hopkins"
      ]
    }
  },
  "intervention_protocol": {
    "ai_prediction_arm": {
      "description": "CV risk assessment using AI model",
      "biomarker_collection": "Blood samples at baseline, weekly during intervention, post-intervention",
      "prediction_frequency": "Daily risk score calculation",
      "clinical_integration": "Risk scores provided to clinical team with decision support"
    },
    "standard_care_arm": {
      "description": "Standard cardiovascular risk assessment",
      "assessment_tools": [
        "Framingham Risk Score",
        "ASCVD Risk Calculator"
      ],
      "frequency": "Weekly clinical assessment",
      "biomarkers": "Standard lipid panel, basic metabolic panel"
    }
  },
  "outcome_measures": {
    "primary": {
      "measure": "Concordance between AI prediction and clinical outcomes",
      "metric": "Area Under ROC Curve (AUC)",
      "target_performance": "AUC \u2265 0.80",
      "non_inferiority_margin": 0.1
    },
    "secondary": [
      "Sensitivity and specificity for high-risk detection",
      "Time to risk elevation detection",
      "Clinical workflow integration success",
      "Healthcare provider satisfaction scores",
      "Cost per quality-adjusted life year (QALY)"
    ]
  },
  "statistical_plan": {
    "primary_analysis": "Intention-to-treat comparison of AUC values",
    "sample_size_calculation": {
      "power": 0.8,
      "alpha": 0.05,
      "effect_size": 0.15,
      "estimated_n_per_group": 100
    },
    "interim_analyses": "At 50% enrollment for futility and safety",
    "multiple_comparisons": "Bonferroni correction for secondary endpoints"
  }
}